Bluesky · Hashtag

#NovoNordisk

48
posts · 30d
24
users
2
posts / day
2.0
posts / user
+ 317% vs last week

#NovoNordisk is an active hashtag on Bluesky. In the last 30 days, 24 people shared 48 posts with it — around 2 a day. Activity is up 317% versus the previous week, peaking on Aug 5 with 11 posts.

#NovoNordisk posts per day (last 30 days)

Posts with #NovoNordisk

Christian Odendahl
@codendahl.bsky.social
over 1 year ago
"Frederiksen held a meeting with chief executives of large Danish companies including #NovoNordisk and Carlsberg last week to discuss Trump’s threats, including potential tariffs against her country."
5 19 197
midgardfinance.com
@midgardfinance.com
about 1 year ago
Novo Nordisk’s amycretin 🐂💉 dropped impressive data at ADA 2025: -24% weight loss at 36 wks (60 mg) vs placebo −1%. Lower doses also strong: 20 mg −22% 5 mg −16% 1.25 mg −10% No plateau yet; Phase 3 ahead! 🔥 #NovoNordisk #ADA2025 #Amycretin
Clinical trial results for subcutaneous amycretin vs placebo across multiple doses.

Panel A plots observed mean percentage weight loss from baseline to week 36 for amycretin 60 mg, clearly outperforming placebo, which remains stable near baseline.

Panel B summarizes the 36-week result: amycretin 60 mg achieved a significant estimated treatment difference (ETD) of −23.2% compared to placebo.

Panel C shows percentage weight loss for lower amycretin doses (20 mg, 5 mg, 1.25 mg) versus placebo through varying durations (20-36 weeks). All doses show meaningful, sustained weight reduction, with placebo groups remaining stable or slightly increasing.

Panel D summarizes ETDs: 20 mg −23.9%, 5 mg −18.6%, and 1.25 mg −11.7%, each significantly better than placebo.

These data confirm robust, dose-dependent efficacy of subcutaneous amycretin for weight loss, with no plateau observed.

#$NOVO-B #$NOVO-B.CO $NVO.US #$NVO $NVO
1 3 10

Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.